IJNPPG GLD 13

WHAT THE CHALLENGE TO BE SUBJECT RESEARCH?

• The active role they play in their health care

• Undergo procedure as required

• They may be unpleasant side effects to experimental treatment

• Complex dosage requirements

HOW PATIENT AND FAMILY MEMBERS GAINING INFORMATION REGARDING RESEARCH ?

• Social Media Platform

• Patient Referral

• physician

• Corporate Social Responsibility

HOW MANY GLD REFERRED TO HUMAN SUBJECT RESEARH AT IJN?

ACCESS TO HUMAN SUBJECT RESEARCH REFER TO GLD........

WHAT ARE BENEFITS TO BE A SUBJECT RESEARCH?

• Receive regular and careful medical attention from research team

• Contact investigator by email or phone when feel discomforts or adverse event during clinical trial

• No additional expenses when participating in research

• Attend new appointment and clinic visit as prescheduled

WHAT GENERAL INFORMATIONS THAT POTENTIAL PATIENTS AND FAMILY MEMBERS NEED TO KNOW BEFORE PARTICIPATE IN THE RESEARCH?

• A statement that those part of the research are experimental

• Patient need to sign consent before to get know about research

• Patient need to decide immediately after explanation about research were given

• Patient can refuse or withdraw at anytime

AS IJNRSB, ARE GLD12 - GLD19 APPLICABLE TO OUR COMPANY?

• No answer

• Yes

• No

WHAT THE PRIMARY OBJECTIVE OF IMPLEMENTING GLD12-GLD19 IN OUR INSTITUTION?

• JCI requirement

• To protect patients right and well-being as human subject research

• To be a global center of excellence in integrated cardiovascular and thoracic care

• to provide the best patient services with the safest and highest quality care

WHAT ARE THE KEY COMPONENTS OF GLD12-GLD19 IMPLEMENTATION?

• Training and education

• Documentation and record-keeping

• Monitoring and evaluation

• All of the above

WHAT ARE THE CONSEQUENCES OF NON-COMPLIANCE WITH GLD12-GLD19?

• Fines and penalties

• Loss of accreditation

• Legal action

• All of the above